Fresh2 News

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Liang Zhijun

Jan 26 16:35 ET

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Tian Honggang

Jan 26 16:32 ET

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Pu Tianruo

Jan 26 16:31 ET

Fresh2 | 3: Initial statement of beneficial ownership of securities-Officer Li Xiaoyu

Jan 26 16:31 ET

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Zhao Zhigang

Jan 26 16:31 ET

Fresh2 | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Xu Haohan

Jan 16 00:00 ET

Fresh2 | 3: Initial statement of beneficial ownership of securities-Officer Xu Haohan

Jan 5 00:00 ET

Fresh2 | SC 13D: Statement of acquisition of beneficial ownership by individuals-Haohan Xu(24.37%),Immensus LLC(22.53%)

Jul 27, 2023 16:10 ET

AnPac Bio-Medical Science | SC 13G: Statement of acquisition of beneficial ownership by individuals-ST. FORTUNE GROUP LLC(12.81%),Duo Liu(12.81%)

Mar 24, 2023 06:09 ET

AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(0.06%),Chris Chang Yu(0.06%)

Oct 12, 2022 16:45 ET

AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(0.06%),Chris Chang Yu(0.06%)

Jun 29, 2022 06:05 ET

AnPac Bio-Medical Science | D: Filing D

Jun 13, 2022 06:06 ET

AnPac Bio-Medical Science | D: Filing D

Jun 13, 2022 06:04 ET

AnPac Bio-Medical Science | D: Filing D

May 27, 2022 16:45 ET

AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(2.69%),Chris Chang Yu(2.69%)

Feb 14, 2022 16:03 ET

AnPac Bio-Medical Science | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Feb 16, 2021 09:22 ET

AnPac Bio-Medical Science | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 12, 2021 15:21 ET

AnPac Bio-Medical Science | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 11, 2021 15:19 ET

AnPac Bio-Medical Science | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 11, 2021 15:13 ET

AnPac Bio-Medical Science | D: Filing D

Aug 24, 2020 16:16 ET